TIMOTHY DALY: Open Payments
NPI 1003074006 · SOUDERTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$460 in 24 payments from 10 companies in 2025. Trend: 2023 $171 · 2024 $346 · 2025 $460
Food & beverage: $460
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $198 |
| Astellas Pharma US Inc | 2 | $66 |
| ABBVIE INC. | 2 | $35 |
| PFIZER INC. | 2 | $34 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $32 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $23 |
| GlaxoSmithKline, LLC. | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| Lilly USA, LLC | 1 | $16 |
| Merck Sharp & Dohme LLC | 1 | $15 |
Products named: Rybelsus, Ozempic, Veozah, VRAYLAR, NURTEC ODT, Kerendia, XIFAXAN, TRELEGY ELLIPTA.
Industry payments across PA — which companies pay providers there.
